Published in Am J Physiol Regul Integr Comp Physiol on November 28, 2012
Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia. Hypertension (2014) 1.41
Preeclampsia: long-term consequences for vascular health. Vasc Health Risk Manag (2015) 1.08
Endothelial dysfunction and preeclampsia: role of oxidative stress. Front Physiol (2014) 1.04
Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol (2015) 0.86
The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol (2014) 0.83
Maternal circulating angiogenic factors in twin and singleton pregnancies. Am J Obstet Gynecol (2014) 0.83
Immune Mechanisms Linking Obesity and Preeclampsia. Biomolecules (2015) 0.81
Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system. Int J Pediatr (2013) 0.80
Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension. Hypertension (2016) 0.79
Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia. PLoS One (2015) 0.77
Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the Rat. PLoS One (2015) 0.77
A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS One (2014) 0.77
Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clin Rev Allergy Immunol (2017) 0.77
Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway. FASEB J (2014) 0.76
Role of Tumor Necrosis Factor-α and Natural Killer Cells in Uterine Artery Function and Pregnancy Outcome in the Stroke-Prone Spontaneously Hypertensive Rat. Hypertension (2016) 0.75
Vitamin D supplementation reduces some AT1-AA induced downstream targets implicated in preeclampsia including hypertension. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Spectrum of Factors Triggering Endothelial Dysfunction in PIH. J Clin Diagn Res (2016) 0.75
Pathophysiology and Current Clinical Management of Preeclampsia. Curr Hypertens Rep (2017) 0.75
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int (2007) 2.87
Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology (2004) 2.83
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension (2007) 2.53
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res (2004) 2.52
Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol (1997) 2.46
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension (2008) 2.42
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens (2010) 2.23
Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension (2005) 2.22
A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod (1998) 2.12
Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) (2009) 2.10
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab (2003) 2.07
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension (2005) 1.95
Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab (2001) 1.94
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med (2006) 1.94
Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol (1998) 1.83
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension (2008) 1.78
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension (2008) 1.65
Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep (2007) 1.65
Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta (2000) 1.64
Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ (2009) 1.59
Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab (1997) 1.50
Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res (2006) 1.48
Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens (2009) 1.41
Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology (2004) 1.33
Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol (2007) 1.15
Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol (2005) 1.12
Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension (2008) 1.10
Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta (2008) 1.07
Invasive cytotrophoblast apoptosis in pre-eclampsia. Hum Reprod (1999) 0.98
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens (2009) 0.95
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol (2007) 2.70
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension (2007) 2.53
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens (2010) 2.23
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension (2006) 2.11
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 2.00
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension (2005) 1.95
Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension (2005) 1.95
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med (2006) 1.94
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension (2009) 1.82
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension (2008) 1.78
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension (2008) 1.72
Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension (2013) 1.71
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension (2008) 1.65
Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep (2007) 1.65
Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension (2006) 1.58
Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension (2009) 1.49
Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension (2008) 1.45
L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension (2004) 1.44
Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens (2009) 1.41
Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens (2008) 1.38
Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol (2002) 1.36
An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.31
Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens (2007) 1.26
Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens (2011) 1.24
Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens (2002) 1.23
Role of reactive oxygen species in endothelin-induced hypertension. Hypertension (2003) 1.21
Hypertension: physiology and pathophysiology. Compr Physiol (2012) 1.18
Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension (2011) 1.14
Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol (2010) 1.14
Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens (2011) 1.13
Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med (2008) 1.07
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol (2011) 1.04
Dietary salt enhances benzamil-sensitive component of myogenic constriction in mesenteric arteries. Am J Physiol Heart Circ Physiol (2007) 1.04
Mechanisms and potential therapies for preeclampsia. Curr Hypertens Rep (2011) 1.02
Role of sex steroids in modulating tumor necrosis factor alpha-induced changes in vascular function and blood pressure. Am J Hypertens (2007) 1.02
Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol (2010) 1.00
Inflammatory cytokines, vascular function, and hypertension. Am J Physiol Regul Integr Comp Physiol (2004) 0.99
Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2002) 0.99
Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol (2005) 0.97
Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.96
Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. Int J Interferon Cytokine Mediat Res (2011) 0.96
Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. J Hypertens (2011) 0.95
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens (2009) 0.95
Sildenafil attenuates placental ischemia-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2013) 0.94
Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. Hypertension (2012) 0.93
L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.91
Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J Hypertens (2011) 0.91
TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol (2002) 0.88
Renal medullary endothelin-1 is decreased in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.88
Endothelin-induced increases in Ca2+ entry mechanisms of vascular contraction are enhanced during high-salt diet. Hypertension (2002) 0.88
Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens (2013) 0.87
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol (2009) 0.86
Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Hypertension (2004) 0.86
Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens (2010) 0.86
Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. Am J Hypertens (2002) 0.86
Matrix metalloproteinases as drug targets in preeclampsia. Curr Drug Targets (2013) 0.85
Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure. Am J Physiol Heart Circ Physiol (2002) 0.85
Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade. PLoS One (2011) 0.85
Obese melanocortin-4 receptor-deficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Rep (2013) 0.84
Angiotensin II regulation of renal vascular ENaC proteins. Am J Hypertens (2009) 0.84
Placental ischemia impairs middle cerebral artery myogenic responses in the pregnant rat. Hypertension (2011) 0.83
Vascular endothelial growth factor inhibitors and hypertension: a central role for the kidney and endothelial factors? Hypertension (2009) 0.83
Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications. Curr Opin Nephrol Hypertens (2012) 0.83
[The heart during pregnancy]. Rev Esp Cardiol (2011) 0.83
Evaluation of a rat model of preeclampsia for HELLP syndrome characteristics. J Soc Gynecol Investig (2003) 0.82
Bilirubin, renal hemodynamics, and blood pressure. Front Pharmacol (2012) 0.81
Inducible nitric oxide synthase inhibition attenuates renal hemodynamics during pregnancy. Hypertension (2002) 0.81
Low-salt diet enhances vascular reactivity and Ca(2+) entry in pregnant rats with normal and reduced uterine perfusion pressure. Hypertension (2002) 0.79
Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant rats. Am J Hypertens (2009) 0.79
Heme oxygenase in pregnancy and preeclampsia. Curr Opin Nephrol Hypertens (2013) 0.78
Hypertension and cardiovascular disease in women. Hypertension (2008) 0.77
Euglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental antiangiogenic and inflammatory factors. Am J Hypertens (2013) 0.77
Heme oxygenase-1 promotes migration and β-epithelial Na+ channel expression in cytotrophoblasts and ischemic placentas. Am J Physiol Regul Integr Comp Physiol (2014) 0.77
Promoting physiology as an essential element in translational research. Physiology (Bethesda) (2012) 0.76
Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats. J Hypertens (2016) 0.75
ACE2 and ANG-(1-7) in the gravid uterus: the new players on the block. Am J Physiol Regul Integr Comp Physiol (2008) 0.75
Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart. J Vis Exp (2016) 0.75
Placental ischemia induces changes in gene expression in chorionic tissue. Mamm Genome (2014) 0.75